Sonitus Continues Climb Toward Reimbursement With Series D
This article was originally published in Start Up
Executive Summary
Early last year, Sonitus Medical obtained 510(k) notification for its non-surgical hearing assistance device to be used in patients with single-sided deafness. The culmination of five years of work, the FDA clearance positioned Sonitus to compete in, and company officials hope ultimately to expand, the $100 million market for devices for conductive hearing loss. But to do that effectively, the company still needs to convince Centers for Medicaid and Medicare Services and private payors.